Evidence map›Paper›PMID 24862762›Full record

ArticleNeoplasia (New York, N.Y.)2014

NHERF1/EBP50 controls morphogenesis of 3D colonic glands by stabilizing PTEN and ezrin-radixin-moesin proteins at the apical membrane.

Maria-Magdalena Georgescu, Gilbert Cote, Nitin Kumar Agarwal, Charles L White

Open access · goldAbstract read
In one paragraph

Article in Neoplasia (New York, N.Y.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. ERM-1 Phosphorylation and NRFL-1 Redundantly Control Lumen Formation in theFrontiers in cell and developmental biology · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Maria-Magdalena GeorgescuDepartment of Pathology, The University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: maria-magdalena.georgescu@phhs.org.
Gilbert CoteDepartment of Endocrine Neoplasia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Nitin Kumar AgarwalDepartment of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Charles L WhiteDepartment of Pathology, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
The University of Texas MD Anderson Cancer Center · USThe University of Texas Southwestern Medical Center · US

Funding

Connecting PTEN and NF2 cancer predisposition syndromesR01CA107201 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI GEORGESCU, MARIA-MAGDALENA · 2005 to 2009
$1.6M
NCI NIH HHS NCI-CA107201NCI NIH HHS R01 CA107201
6 · The paper itself

Abstract

Na(+)/H(+) exchanger 3 regulating factor 1/ezrin-radixin-moesin (ERM)-binding phosphoprotein 50 (NHERF1/EBP50), an adaptor molecule that interacts with the ERM-neurofibromatosis type 2 family of cytoskeletal proteins through its ERM-binding region and with phosphatase and tensin homolog (PTEN) and β-catenin through its PDZ domains, has been recently implicated in the progression of various human malignancies, including colorectal cancer (CRC). We report here that NHERF1 controls gland morphogenesis, as demonstrated in three-dimensional (3D) human intestinal glands developing from a single nonpolarized cell. Starting from the early two-cell developmental stage, NHERF1 concentrates at the cellular interface in a central membrane disc that marks the apical pole delimiting the forming lumen. NHERF1 depletion leads to severe disruption of the apical-basal polarity, with formation of enlarged and distorted cell spheroids devoid of a central lumen. This characteristic and the increased number of mitoses in NHERF1-depleted spheroids, including multipolar ones, mimic high-grade dysplasia lesions observed in CRC progression. NHERF1 ERM-binding or PDZ-domain mutants fail to localize apically and impair gland formation most likely by outcompeting endogenous ligands, with the latter mutant completely aborting gland development. Examination of NHERF1 ligands showed that even if both ezrin and moesin colocalized with NHERF1 at the apical membrane, moesin but not ezrin depletion disrupted morphogenesis similarly to NHERF1. NHERF1 depletion resulted also in membrane displacement of PTEN and nuclear translocation of β-catenin, events contributing to polarity loss and increased proliferation. These findings reveal an essential role of NHERF1 in epithelial morphogenesis and polarity and validate this 3D system for modeling the molecular changes observed in CRC.

Indexed as

beta CateninCell LineCell MembraneColonCytoskeletal ProteinsEzrinHumansIntestinal MucosaMicrofilament ProteinsMorphogenesisPDZ DomainsPhosphoproteinsProtein BindingProtein Interaction Domains and MotifsProtein TransportPTEN Phosphohydrolasebeta CateninCytoskeletal ProteinsEzrinMicrofilament ProteinsmoesinPhosphoproteinsPTEN Phosphohydrolasesodium-hydrogen exchanger regulatory factorSodium-Hydrogen Exchangers

Identifiers

PMID24862762
PMCPMC4094837
OpenAlexW2089983140

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.